Insider Transactions in Q4 2024 at Summit Therapeutics Inc. (SMMT)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 03
2024
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
315,681
+3.0%
|
$315,681
$1.58 P/Share
|